OVERLAND PARK, Kan.; November 12, 2024 (Business Wire) – Dr. Vince Clinical Research (DVCR) is pleased to announce the addition of a cutting-edge clinical laboratory within the main building of its research campus. This new laboratory will significantly enhance the capabilities of its clinical pharmacology unit by enabling in-house safety laboratory testing and streamlining operations.
“The addition of our clinical laboratory aligns with DVCR’s commitment to innovation and excellence in the clinical research industry,” stated Dr. Brad Vince, CEO and Chief Medical Officer. “This new laboratory meets the highest standards of accuracy, reliability and redundancy, offers a full range of testing capabilities and allows us to provide specialized safety lab services to our biopharmaceutical clients,” added Dr. Vince.
The in-house laboratory will perform a comprehensive range of safety tests, including chemistry and immunoassay, hematology with differential for complete blood counts, coagulation and urinalysis with microscopy. These essential tests will be conducted using advanced instrumentation, each purchased in duplicate to ensure continuous operation and minimize the potential for downtime.
“Adding this laboratory to our facility represents a significant advancement in our mission to provide timely, reliable and high-quality data to our clients,” said Shari Clark, Director of Laboratory Operations at DVCR. “By conducting safety testing on-site, we can deliver faster results, minimize logistical challenges and ultimately enhance the overall efficiency of our clinical trials.”
Each instrument in the laboratory has undergone a rigorous verification and validation process before being placed into service. Integrating these instruments with DVCR’s electronic data capture system allows for real-time results and review capabilities, further enhancing the speed and accuracy of data reporting. The laboratory operates under a comprehensive Quality Management Program and is fully certified by Clinical Laboratory Improvement Amendments (CLIA).
About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials.
Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.
For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube.
DVCR Contact
Zach Bader
Vice President, Business Development
(913) 333-3000
Dr. Vince Clinical Research
info@drvince.com